Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1983-03-18
1985-07-02
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548215, 528125, 528126, 528128, 528224, 528227, C07D26306, A61K 3142
Patent
active
045267880
ABSTRACT:
This disclosure describes novel polymeric 1,4-bis-[(1,3-oxazolidin-3-yl)alkylamino]anthraquinones prepared by condensation of 1,4-bis-[(2-hydroxyalkylamino)alkylamino]anthraquinones with dialdehydes which are useful as anti-cancer agents.
REFERENCES:
patent: 2865925 (1958-12-01), Bolen
patent: 3334100 (1967-08-01), Zenitz
patent: 4275010 (1981-06-01), Murdock
patent: 4410524 (1983-10-01), Murdock
Murdock Keith C.
Webb Richard L.
American Cyanamid Company
Conroy, Jr. Edward A.
Daus Donald G.
Gibson S. A.
LandOfFree
Polymeric[[(oxazolidinyl)alkyl]amino]anthraquinones does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polymeric[[(oxazolidinyl)alkyl]amino]anthraquinones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polymeric[[(oxazolidinyl)alkyl]amino]anthraquinones will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-380881